4. In the Consumer Rights Act 2015(1), Schedule 5(2) (investigatory powers etc.) is amended as follows—
(a)in paragraph 8, after the definition of “Regulation (EU) 2017/745 on medical devices” insert—
““Regulation (EU) 2017/746 on in vitro diagnostic medical devices” means Regulation (EU) 2017/746 of the European Parliament and of the Council of 5 April 2017 on in vitro diagnostic medical devices and repealing Directive 98/79/EC and Commission Decision 2010/227/EU;”;
(b)in paragraph 19(7A)(a)—
(i)at the end of sub-paragraph (iii), omit “or”;
(ii)at the end of sub-paragraph (iv), omit “and” and insert—
“or
(v)Regulation (EU) 2017/746 on in vitro diagnostic medical devices, and”;
(c)in paragraph 30A(3)(b), after “Regulation (EU) 2017/745 on medical devices” insert “or Regulation (EU) 2017/746 on in vitro diagnostic medical devices”.
Schedule 5 was amended by the Medicines and Medical Devices Act 2021, S.I. 2021/858 and S.I. 2021/905; there are other amending instruments but none is relevant.